| Date Filed | Type | Description |
| 09/29/2023 |
4
| Albers Jeffrey W. (Director) has filed a Form 4 on Blueprint Medicines Corp|
Txns:
| Sold 5,600 shares
@ $48.84, valued at
$273.5k
Sold 12,102 shares
@ $49.93, valued at
$604.3k
Sold 400 shares
@ $50.5, valued at
$20.2k
Sold 6,898 shares
@ $50.17, valued at
$346.1k
Exercised 18,102 options to buy
@ $1.87, valued at
$33.9k
Exercised 6,898 options to buy
@ $1.87, valued at
$12.9k
|
|
| 08/24/2023 |
144
| Form 144 - Report of proposed sale of securities: |
| 03/08/2023 |
4
| Albers Jeffrey W. (Director) has filed a Form 4 on Blueprint Medicines Corp|
Txns:
| Sold 9,474 shares
@ $45.72, valued at
$433.2k
Sold 319 shares
@ $44.27, valued at
$14.1k
|
|
| 12/07/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 08/23/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 08/18/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 08/10/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/30/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/16/2022 |
4
| Albers Jeffrey W. (Director) has filed a Form 4 on Kymera Therapeutics, Inc.|
Txns:
| Granted 12,000 options to buy
@ $14.18, valued at
$170.2k
|
|
| 05/18/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 04/08/2022 |
4
| Albers Jeffrey W. (CEO AND PRESIDENT) has filed a Form 4 on Blueprint Medicines Corp|
Txns:
| Sold 5,000 shares
@ $70.11, valued at
$350.6k
Exercised 5,000 options to buy
@ $15.01, valued at
$75.1k
|
|
| 03/08/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 03/03/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 11/17/2021 |
4
| Albers Jeffrey W. (CEO and President) has filed a Form 4 on Blueprint Medicines Corp|
Txns:
| Sold 21,906 shares
@ $114.73, valued at
$2.5M
Sold 7,894 shares
@ $113.92, valued at
$899.3k
Sold 100 shares
@ $113.25, valued at
$11.3k
Sold 100 shares
@ $112.14, valued at
$11.2k
Exercised 7,500 options to buy
@ $1.87, valued at
$14k
Exercised 22,500 options to buy
@ $15.01, valued at
$337.7k
|
|
| 11/03/2021 |
4
| Albers Jeffrey W. (CEO and President) has filed a Form 4 on Blueprint Medicines Corp|
Txns:
| Sold 5,000 shares
@ $115.16, valued at
$575.8k
Exercised 5,000 options to buy
@ $15.01, valued at
$75.1k
|
|
| 08/30/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 08/23/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/17/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/03/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 05/14/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 03/05/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 03/03/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 12/16/2020 |
4
| Albers Jeffrey W. (CEO and President) has filed a Form 4 on Blueprint Medicines Corp|
Txns:
| Sold 5,000 shares
@ $119.18, valued at
$595.9k
Exercised 5,000 options to buy
@ $8.8, valued at
$44k
|
|
| 11/18/2020 |
4
| Albers Jeffrey W. (CEO and President) has filed a Form 4 on Blueprint Medicines Corp|
Txns:
| Sold 4,127 shares
@ $100.11, valued at
$413.2k
Sold 4,869 shares
@ $99.55, valued at
$484.7k
Sold 4,483 shares
@ $98.13, valued at
$439.9k
Sold 6,521 shares
@ $97.61, valued at
$636.5k
Exercised 20,000 options to buy
@ $8.8, valued at
$176k
|
|
| 10/09/2020 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 08/21/2020 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 08/21/2020 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 08/20/2020 |
3
| Form 3 - Initial statement of beneficial ownership of securities: |
| 06/09/2020 |
4
| Albers Jeffrey W. (Director) has filed a Form 4 on Magenta Therapeutics, Inc.|
Txns:
| Granted 18,188 options to buy
@ $9.99, valued at
$181.7k
|
|
| 05/14/2020 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 03/25/2020 |
4
| Albers Jeffrey W. (CEO and President) has filed a Form 4 on Blueprint Medicines Corp|
Txns:
| Sold 484 shares
@ $55.34, valued at
$26.8k
Sold 3,293 shares
@ $54.62, valued at
$179.9k
Sold 1,936 shares
@ $53.54, valued at
$103.7k
Sold 2,100 shares
@ $52.11, valued at
$109.4k
Sold 8,850 shares
@ $51.3, valued at
$454k
Sold 3,337 shares
@ $50.4, valued at
$168.2k
Exercised 20,000 options to buy
@ $1.87, valued at
$37.4k
Exercised 80 options to buy
@ $1.87, valued at
$149.6
Exercised 19,920 options to buy
@ $8.8, valued at
$175.3k
|
|
| 03/11/2020 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 03/03/2020 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 11/20/2019 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
|